Chimerix Inc (CMRX)
0.8987
-0.05
(-5.40%)
USD |
NASDAQ |
Nov 14, 16:00
0.96
+0.06
(+6.82%)
After-Hours: 05:28
Chimerix Cash and Short Term Investments (Quarterly): 136.23M for Sept. 30, 2024
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 136.23M |
| June 30, 2024 | 148.17M |
| March 31, 2024 | 159.03M |
| December 31, 2023 | 182.84M |
| September 30, 2023 | 194.48M |
| June 30, 2023 | 205.76M |
| March 31, 2023 | 214.75M |
| December 31, 2022 | 217.33M |
| September 30, 2022 | 284.63M |
| June 30, 2022 | 42.79M |
| March 31, 2022 | 53.38M |
| December 31, 2021 | 88.37M |
| September 30, 2021 | 122.56M |
| June 30, 2021 | 132.03M |
| March 31, 2021 | 144.98M |
| December 31, 2020 | 78.96M |
| September 30, 2020 | 87.76M |
| June 30, 2020 | 95.95M |
| March 31, 2020 | 103.02M |
| December 31, 2019 | 113.48M |
| September 30, 2019 | 116.72M |
| June 30, 2019 | 158.40M |
| March 31, 2019 | 171.59M |
| December 31, 2018 | 186.53M |
| Date | Value |
|---|---|
| September 30, 2018 | 183.36M |
| June 30, 2018 | 174.76M |
| March 31, 2018 | 160.45M |
| December 31, 2017 | 151.52M |
| September 30, 2017 | 149.72M |
| June 30, 2017 | 148.53M |
| March 31, 2017 | 161.70M |
| December 31, 2016 | 232.02M |
| September 30, 2016 | 249.67M |
| June 30, 2016 | 272.82M |
| March 31, 2016 | 263.34M |
| December 31, 2015 | 220.33M |
| September 30, 2015 | 220.80M |
| June 30, 2015 | 258.33M |
| March 31, 2015 | 174.50M |
| December 31, 2014 | 234.58M |
| September 30, 2014 | 188.42M |
| June 30, 2014 | 200.60M |
| March 31, 2014 | 99.92M |
| December 31, 2013 | 109.98M |
| September 30, 2013 | 116.90M |
| June 30, 2013 | 123.03M |
| March 31, 2013 | 22.92M |
| December 31, 2012 | 29.76M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
42.79M
Minimum
Jun 2022
284.63M
Maximum
Sep 2022
140.32M
Average
134.13M
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Abbott Laboratories | 7.788B |
| Emergent BioSolutions Inc | 149.90M |
| SIGA Technologies Inc | 99.27M |
| Tonix Pharmaceuticals Holding Corp | 4.156M |
| Geovax Labs Inc | 1.562M |